Unternehmen BetterLife Pharma Inc. Other OTC
Aktien
A2P7XN
CA08772P2026
BETRF
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17.09.07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26.12.10 |
Chief Operating Officer | 67 | - | |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05.02.15 |
David Melles
IRC | Investor Relations Contact | - | 29.09.21 |
Anthony Calandra
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17.09.07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21.01.20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05.02.15 |
Ralph Pullen
BRD | Director/Board Member | 79 | 05.05.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 117 079 397 | 85 332 281 ( 72,88 %) | 0 | 72,88 % |
Unternehmenskontakt
BetterLife Pharma, Inc.
1275 West 6th Avenue Suite 300
V6H 1A6, Vancouver
+
http://www.abetterlifepharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+18.34% | 125 Mrd. | |
+15.06% | 108 Mrd. | |
-6.39% | 23.64 Mrd. | |
+2.39% | 22.39 Mrd. | |
-12.11% | 17.78 Mrd. | |
-41.64% | 16.43 Mrd. | |
-12.07% | 16.34 Mrd. | |
+1.05% | 13.56 Mrd. | |
+25.87% | 11.59 Mrd. |